Over the current book year the total revenue will be 23,91 billion USD (consensus estimates). This is slightly more than 2019's revenue of 22,32 billion USD.
The analysts expect for 2020 a net profit of 6,64 billion USD. For this year the majority of the analysts, consulted by press agency Thomson Reuters, expects a profit per share of 7,28 USD. The price/earnings-ratio therefore equals 20,62.
For this year the analysts expect a dividend of 2,99 USD per share. The dividend yield is then 1,99 percent. The average dividend yield of the pharmaceutical companies is a moderate 0,38 percent.
Lilly (Eli) & Co.'s market capitalization is based on the number of outstanding shares around 158,73 billion USD. The Lilly (Eli) & Co. stock was the past 12 months quite unstable. Since last October the stock is even 40 percent higher. This year the stock price moved between 101 and 171 dollar.
Click here for dividend Lilly (Eli) & Co.. At 19.16 the stock trades 1,09 percent lower at 150,08 USD.
Analist.nl Nieuwsdienst: +31 084-0032-842
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.